Background Effective decongestion is a key therapeutic goal during hospitalisation for acute heart failure (HF), but the ...
For more than two decades, the crucial dilemma of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) has remained unchanged: the same therapies used to treat myocardial ...
Background The impact of COVID-19 in hypertrophic cardiomyopathy (HCM), particularly in the post-vaccine era, remains ...
Pericarditis remains a clinical diagnosis. No single symptom, biomarker, electrocardiographic pattern or imaging finding is sufficiently sensitive and specific across the full spectrum of disease. The ...
Background Pericarditis may be associated with significant morbidity and mortality and can be a clinically challenging entity ...
Background Obesity is a major contributor to cardiovascular disease (CVD). Different fat depots may have distinct effects on ...
In the early 2000s, the natural history of heart failure (HF) was vividly illustrated, highlighting a defining feature of HF progression: a prolonged course of fluctuating yet steadily worsening ...
Background The Valve Academic Research Consortium (VARC) recently proposed a definition of high bleeding risk (HBR) for patients undergoing transcatheter aortic valve implantation (TAVI). This study ...
Background Hypochloraemia has emerged as a prognostic marker in heart failure, although the mechanisms underlying chloride ...
2 Department of Cardiovascular Sciences, University of Leicester, Faculty Member of the NIHR Leicester Cardiovascular Biomedical Research Unit, Leicester, UK Following this review of evidence and ...
Objectives: To quantify the incidence of major adverse events (AEs) occurring in hospital or within 30 days after surgery in patients undergoing coronary artery bypass graft (CABG) surgery and to ...
Correspondence to Dr Sakineh Shab-Bidar, Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran 14155/6117, Iran; s_shabbidar{at ...